Cargando…
2619. Clinical Characteristics and Etiology of Community-Acquired Pneumonia in Children: A Contemporary, Prospective, Multicenter Study in Ohio, 2015–2018
BACKGROUND: Worldwide, pneumonia is the leading cause of death in children <5 years of age and the second most common reason for hospitalization in children in the United States and Europe. This study was designed to describe the clinical characteristics and etiology of community-acquired pneumon...
Autores principales: | Yun, Ki Wook, Wallihan, Rebecca, Desai, Ankita P, Alter, Sherman J, Ambroggio, Lilliam, Cohen, Daniel M, El-Assal, Osama, Marzec, Sarah, Florin, Todd A, Keaton, Meghan, Shah, Samir S, Mejias, Asuncion, Ramilo, Octavio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810721/ http://dx.doi.org/10.1093/ofid/ofz360.2297 |
Ejemplares similares
-
2210. Nasopharyngeal Detection of Streptococcus pneumoniae and Clinical Disease Severity in Children with Community-Acquired Pneumonia (CAP)
por: Wook Yun, Ki, et al.
Publicado: (2019) -
261. Alternative Antibiotic Prescribing for Community Acquired Pneumonia (CAP) in Pediatric Patients in Relation to Allergy Status
por: Desai, Ankita, et al.
Publicado: (2018) -
999. Nasal Mucosal Cytokines: Potential Biomarkers for Pediatric Pneumonia Severity and Etiology
por: Sayegh, Rouba, et al.
Publicado: (2021) -
Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
por: Mejías, Asunción, et al.
Publicado: (2008) -
2783. Expansion of Monocytic Myeloid-Derived Suppressor Cells in Infants with Severe Respiratory Syncytial Virus (RSV) Infection
por: Bedoya, Santiago Acero, et al.
Publicado: (2019)